MedPath

Treatment of Acute Malnutrition in Outpatient Care Services in Venezuela: a Prospective Cohort Research

Completed
Conditions
Wasting
Acute Malnutrition in Childhood
Child Malnutrition
Interventions
Procedure: Standard protocol
Procedure: Simplified protocol
Registration Number
NCT06287827
Lead Sponsor
UNICEF - Venezuela
Brief Summary

The goal of this observational study is to compare the effectiveness, safety, and efficiency of the simplified protocol, which includes the following three modifications: a) use of a single treatment product (RUTF), b) reduced dose, c) expanded cut-offs, with the standard protocol based on the 2023 World Health Organization (WHO) guidelines for the prevention and treatment of acute malnutrition in children aged 6 to 59 months, in outpatient care services of the states of Bolívar, Capital District, La Guaira, and Miranda of Venezuela.

The main question it aims to answer is:

What is the effectiveness, safety, and efficiency of the simplified protocol, which includes these three modifications (use of a single treatment product (RUTF), reduced dose, expanded cut-offs) when compared to a standard protocol that is based on the 2023 WHO guidelines for the prevention and treatment of acute malnutrition in children aged 6 to 59 months in the outpatient care services of the states of Bolívar, Capital District, La Guaira, and Miranda of Venezuela? This prospective cohort, longitudinal study will be conducted in 4 states, treating children aged 6-59 months diagnosed with uncomplicated AM, defined as WHZ \<-2 or mid-upper-arm circumference (MUAC) \<125mm or bilateral edema. Children will be prospectively followed for 16 weeks or until their recovery.

Researchers will compare the simplified protocol cohort with the standard protocol cohort to determine which one has the best effectiveness, safety, and efficiency indicators in the Venezuela context.

The effectiveness of the treatment will be measured by the recovery rate, duration of the treatment, and changes in anthropometry (weight, height, and arm circumference). Other treatment effects will also be measured, including how many are admitted to the hospital, death, and relapse rates from the nutritional program. An economic evaluation component will be incorporated. Total costs will be aggregated and presented as costs per child treated and per child recovered.

Detailed Description

The general objective of the study is to compare the effectiveness, safety, and efficiency of the simplified protocol, which includes the following three modifications: a) use of a single treatment product (RUTF), b) reduced dose, c) expanded cut-offs, with the standard protocol based on the 2023 WHO guidelines for the prevention and treatment of acute malnutrition in children aged 6 to 59 months in outpatient care services in the states Bolívar, Capital District, La Guaira, and Miranda of Venezuela.

This will be a multicentric and prospective cohort study assessing the Simplified Protocol with the Standard Protocol, among children with uncomplicated acute malnutrition. Children will be prospectively followed until their recovery or for a maximum of 16 weeks.

The study will be implemented in 4 Venezuelan states chosen based on their acute malnutrition prevalence and operational constraints.

The protocol will be implemented by health professionals from each institution, duly previously trained in applying the study protocol.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
299
Inclusion Criteria
  • Simplified protocol cohort

    • MUAC <125 mm or
    • Weight-Height/length Z Score <-2 or
    • Mild bipedal pitting oedema.

And all the following:

  • No medical complications

  • Positive appetite test.

    • Standard protocol cohort

SAM:

  • MUAC <115 mm or
  • Weight-Height/length Z Score <-3 or
  • Mild bipedal pitting oedema

And all the following:

  • No medical complications
  • Positive appetite test

MAM (Although MAM cases are not traditionally included, in this study they will be incorporated if they meet the following criteria):

  • MUAC ≥ 115 mm to < 125 mm or
  • Weight-Height/length Z Score ≥ -3 to < -2 and
  • No nutritional oedema

And at least one the following:

  • Failing to recover from moderate wasting after receiving other interventions (counselling alone).
  • Having relapsed to moderate wasting
  • History of severe wasting
  • Households' low socioeconomic status (Determined by Graffar-Mendez-Castellanos method)
  • Co-morbidity (HIV, tuberculosis, or a physical or mental disability that does not jeopardize the anthropometric measurements)
Read More
Exclusion Criteria
  • Both cohorts:

    • Congenital malformations that make anthropometric measurements impossible.
    • Family that intends to leave the study area before four months.
    • Presence of medical condition requiring referral for hospitalization. Presence of medical condition requiring referral for hospitalization.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Standard protocolStandard protocolThe second cohort will be composed of all children between 6 and 59 months of age who attend other predefined outpatient care points in the four states and met the inclusion criteria for this research. Nutritional treatment will be administered to these children, following the WHO Standard Protocol.
Simplified protocolSimplified protocolThe first cohort will be composed of all children between 6 and 59 months of age who attend predefined outpatient care points in the states Distrito Capital, Miranda, and La Guaira. These children must meet the inclusion criteria for the research. For those selected in these centers, the method of nutritional treatment for acute malnutrition will be the simplified protocol. Adaptations in this protocol include: 1. Use of a single treatment product (Ready to use therapeutic food). 2. Reduced dose. 3. Expanded cut-offs.
Primary Outcome Measures
NameTimeMethod
Mid-Upper Arm Circumference (MUAC) gainFrom date of inclusion in the program until the date of recovery or 16th week after inclusion in the program or date of death from any cause, whichever came first

Average Mid-Upper Arm Circumference (MUAC) change in each protocol.

Prevalence of child morbidityFrom date of enrolment until the date of recovery, last documented progression or date of death from any cause, whichever came first.

Defined by the number of days with symptoms of acute respiratory infections, fever, diarrhea (three or more loose or liquid stools per day) and malaria divided by the total number of days observed/reported in the recall period

Duration of the treatmentFrom date of inclusion in the program until the date of recovery or 16th week after inclusion in the program or date of death from any cause, whichever came first

Defined as the average number of weeks spent on treatment (enrollment and recovery) in children 6-59 months of age at enrollment, according to health registers

Weight gainFrom date of inclusion in the program until the date of recovery or 16th week after inclusion in the program or date of death from any cause, whichever came first

Average weight change in each protocol.

Recovery rateFrom date of inclusion in the program until the date of recovery or 16th week after inclusion in the program or date of death from any cause, whichever came first

This indicator is defined as the number of children who recovered from SAM and MAM (WHZ\>-2 and MUAC\>=125mm and the absence of bilateral edema for two consecutive visits, within 16 weeks of enrollment in the program, divided by the total number of treated children.

Number of RUTF delivered per childFrom date of inclusion in the program until the date of recovery or 16th week after inclusion in the program or date of death from any cause, whichever came first

Average number of RUTF delivered per child (SAM/MAM) in each protocol

Cost per childFrom date of inclusion in the program until the date of recovery or 16th week after inclusion in the program or date of death from any cause, whichever came first

Average number of dollars that cost to recovery a child in each cohort

Secondary Outcome Measures
NameTimeMethod
Prevalence of child stuntingAt the date of recovery or 16th week after inclusion in the program or date of death from any cause, whichever came first

Proportion of children with Height-for-age Z-score (LAZ)\<-2 (according to the 2006 World Health Organization reference) at the end of the study

Trial Locations

Locations (4)

Bolivar State Centers

🇻🇪

Puerto Ordaz, Bolivar, Venezuela

Ditrict Capital centers

🇻🇪

Caracas, Capital District, Venezuela

Miranda State Centers

🇻🇪

Santa Lucia, Miranda, Venezuela

La Guaira State Centers

🇻🇪

La Guaira, Venezuela

© Copyright 2025. All Rights Reserved by MedPath